Detalles de la búsqueda
1.
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.
Cancer Lett
; 596: 217001, 2024 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38838764
2.
Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era.
J Immunother Precis Oncol
; 6(3): 150-157, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37637236
3.
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival.
Cancers (Basel)
; 15(20)2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894419
4.
Advances in immune therapies for the treatment of microsatellite instabilityhigh/deficient mismatch repair metastatic colorectal cancer (Review).
Int J Oncol
; 59(3)2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34396449
5.
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.
JAMA Oncol
; 7(12): 1856-1861, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734989
Resultados
1 -
5
de 5
1
Próxima >
>>